# Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension

> **NCT01519635** · PHASE4 · COMPLETED · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 24 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Aliskiren
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT01519635
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01519635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01519635, "Effect of Aliskiren and Hydrochlorothiazide on Kidney Oxygenation in Patients With Hypertension". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01519635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*